Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
Meng-Wei Xiao, Shixin Lin, Zhaohua Shen, et al.
Gastroenterology Research and Practice (2019) Vol. 2019, pp. 1-19
Open Access | Times Cited: 69

Showing 51-75 of 69 citing articles:

Obese Vegetarians and Omnivores Show Different Metabolic Changes: Analysis of 1340 Individuals
Eric Slywitch, Carine Savalli, Antonio Cláudio Goulart Duarte, et al.
Nutrients (2022) Vol. 14, Iss. 11, pp. 2204-2204
Open Access | Times Cited: 4
Role of Probiotics and Gut microbiota in Liver Diseases
Safeena Beevi S S, Biju Pottakkat, S. Narayanan
Asian Journal of Nursing Education and Research (2023), pp. 157-161
Closed Access | Times Cited: 2
Effect of probiotics supplementation on liver stiffness and steatosis in patients with NAFLD
Shahinul Alam
Hepatology forum/Hepatology forum (Online) (2023), pp. 18-24
Open Access | Times Cited: 2
The Effects of Foods on Blood Lipids in Non-alcoholic Fatty Liver Disease (NAFLD)—A Systematic Review and Meta-Analysis
Fredrik Rosqvist, Andreas Rydell, David Iggman
Frontiers in Nutrition (2020) Vol. 7
Open Access | Times Cited: 4
Probiotics—A Promising Novel Therapeutic Approach in the Management of Chronic Liver Diseases
Gokulapriya Ramachandran, Biju Pottakkat
Journal of Medicinal Food (2024) Vol. 27, Iss. 6, pp. 467-476
Closed Access
Meta-analysis of randomized controlled trials of the effects of synbiotics, probiotics, or prebiotics in controlling glucose homeostasis in non-alcoholic fatty liver disease patients
Siqi Ding, Qing Hong, Yuanyue Yao, et al.
Food & Function (2024) Vol. 15, Iss. 19, pp. 9954-9971
Closed Access
Dietary supplementation of probiotic Lactobacillus modulates metabolic dysfunction‐associated steatotic liver disease and intestinal barrier integrity in obesity‐induced mice
Nageena Qayyum, Mohamedelfatieh Ismael, Han Haoyue, et al.
Journal of Food Science (2024)
Open Access
The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment
Gautam Maddineni, Sri J. Obulareddy, Ruchir Paladiya, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 8, pp. 4714-4731
Open Access
Individuals with Metabolic Syndrome show altered fecal lipidomic profiles with no signs of intestinal inflammation or increased intestinal permeability: a pilot study
Mia J. Coleman, Luis M. Espino, Hernan Lebensohn, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Tianyi Ren, Xiaoyan Li, Jian‐Gao Fan
Clinical and Molecular Hepatology (2020) Vol. 27, Iss. 1, pp. 83-86
Open Access | Times Cited: 2
Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network on Hepatitis C (CANHEPC) and the Canadian Association of Hepatology Nurses (CAHN) 2021 Abstracts.

Canadian Liver Journal (2021) Vol. 4, Iss. 2, pp. 125-254
Open Access | Times Cited: 2
The Role of Microbiome in Nonalcoholic Fatty Liver Disease
Hye Won Lee
(2023), pp. 107-118
Closed Access
Non-alcoholic fatty liver disease: from understanding risk factors to finding optimal treatment regimens: A review
Daria Teplyuk, Aliya A. Kaisina, Shabnam Ibragimova, et al.
Consilium Medicum (2023) Vol. 25, Iss. 5, pp. 325-332
Open Access
Gut microbiota modulation as an alternative in the management of non-alcoholic fatty liver disease and obesity
María Juárez‐Fernández
(2023)
Open Access
Probiotics and the gut-liver axis
Amedeo Amedei, Stefano Gitto, Claudia Campani, et al.
Elsevier eBooks (2022), pp. 467-481
Closed Access
Serum CathepsinD in pregnancy: Relation with metabolic and inflammatory markers and effects of fish oils and probiotics
Kati Mokkala, Johanna Gustafsson, Tero Vahlberg, et al.
Nutrition Metabolism and Cardiovascular Diseases (2022) Vol. 32, Iss. 5, pp. 1292-1300
Open Access
Evidências no Uso de Probióticos para Esteatose Hepática Não Alcoólica (NASH) / Evidence on the Use of Probiotics for Non Alcoholic Liver Steatosis (NASH)
Sophia de Araújo Libânio Costa, Larissa Ferreira Marques, Carolina Pantuzzo Leão Alves, et al.
Brazilian Journal of Health Review (2021) Vol. 4, Iss. 2, pp. 4266-4276
Open Access
The place of probiotics in the treatment of non-alcoholic fatty liver disease
T. A. Solomentseva
Modern Gastroenterology (2021), Iss. 3
Closed Access
Modulación de la microbiota intestinal en el tratamiento de la enfermedad de hígado graso no alcohólico y síndrome metabólico. Estudio de un tratamiento experimental con quercetina y de la transferencia de microbiota a ratones libres de gérmenes = Intestinal microbiota modulation in the treatment of non-alcoholic fatty liver disease and metabolic syndrome. Study of an experimental treatment with quercetin and intestinal microbiota transfer to germ-free mice
David Porras Sanabria
(2021)
Open Access
Previous Page - Page 3

Scroll to top